OTC - ACTIVE INGREDIENT SECTION
Active ingredients (in each tablet)
Docusate sodium 8.33mg
Sennosides 1.36mg
Active ingredients (in each tablet)
Docusate sodium 8.33mg
Sennosides 1.36mg
Purposes
Docusate sodium Stool softener laxative
Sennosides Stimulant laxative
Uses
■for the relief of occasional constipation (irregularity)
■generally produces bowel movement in 6 to 12 hours
Warnings
Do not use laxative products for a period longer than 1 week unless directed by a doctor
Ask a doctor before use if you have
■abdominal pain, nausea, or vomiting
■noticed a sudden change in bowel habits that persists over a period of 2 weeks
Ask a doctor or pharmacist before useif you are presently taking mineral oil
Stop use and ask a doctor if
■you have rectal bleeding or failure to have a bowel movement after use of a laxative (may indicate a serious condition)
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.
Frequent or prolonged use of this preparation may result in dependence on laxatives.
Directions
adults and children 12 years and older - take 6 to 12 tablets once or twice a day
children 6 to under 12 years - take 5 to 7 tablets once or twice a day
children 2 to under 6 years - take 3 to 5 tablets once or twice a day
children under 2 years - consult a doctor
■once or twice daily, preferably morning and evening, when needed or as directed by a doctor
■start initial dosage with minimum dose, then adjust it to suit to bowel condition
Other information
■each tablet contains calcium 5 mg
Inactive ingredients caramel, carmellose calcium, cinnamon, dibasic calcium phosphate, FDandC Blue No. 2, fennel, hydroxypropyl methylcellulose, magnesium stearate, mentha oil, microcrystalline cellulose, moutan bark, pharbitis seed, polyoxyethylene (105) polyoxypropylene (5) glycol, silicon dioxide, simethicone, synthetic iron oxide, talc
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49873-404-01 | Sankaijo | 1 in 1 CARTON | TABLET | 1 | 11 | |
| 49873-404-01 | Sankaijo | 150 in 1 BOTTLE | TABLET | 150 | 11 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| docusate sodium | ACTIVE INGREDIENT | F05Q2T2JA0 | 6 | |
| SENNOSIDES | ACTIVE INGREDIENT | 3FYP5M0IJX | 6 | |
| docusate | ACTIVE MOIETY | M7P27195AG | 6 | |
| SENNOSIDES | ACTIVE MOIETY | 3FYP5M0IJX | 6 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | 6 | |
| caramel | INACTIVE INGREDIENT | T9D99G2B1R | 6 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 6 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 6 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | 6 | |
| FENNEL | INACTIVE INGREDIENT | 557II4LLC3 | 6 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 6 | |
| HYPROMELLOSE 2910 (15000 MPA.S) | INACTIVE INGREDIENT | 288VBX44JC | 6 | |
| IPOMOEA NIL SEED | INACTIVE INGREDIENT | I85W45B4WB | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 6 | |
| PAEONIA SUFFRUTICOSA ROOT BARK | INACTIVE INGREDIENT | BUG255FE7X | 6 | |
| PEG/PPG-105/5 COPOLYMER | INACTIVE INGREDIENT | 52901V8XAR | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 6 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49873-404 | 49873-404-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET / ORAL | 25 mg | ||
| caramel | CARAMEL | T9D99G2B1R | SYRUP / ORAL | 207 mg/5ml | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| caramel | CARAMEL | T9D99G2B1R | SOLUTION / ORAL | 11 mg | ||
| caramel | CARAMEL | T9D99G2B1R | SYRUP / ORAL | 207 mg/5ml | ||
| caramel | CARAMEL | T9D99G2B1R | CAPSULE / ORAL | NA | ||
| caramel | CARAMEL | T9D99G2B1R | SUSPENSION / ORAL | 111.12 mg/5ml | ||
| caramel | CARAMEL | T9D99G2B1R | SUSPENSION / ORAL | 111.12 mg/5ml | ||
| caramel | CARAMEL | T9D99G2B1R | GRANULE, FOR SUSPENSION / ORAL | 2.5 mg/5ml | ||
| HYPROMELLOSE 2910 (15000 MPA.S) | HYPROMELLOSE 2910 (15000 MPA.S) | 288VBX44JC | TABLET / ORAL | 29 mg | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | CARBOXYMETHYLCELLULOSE CALCIUM | UTY7PDF93L | TABLET / ORAL | 967 mg | ||
| caramel | CARAMEL | T9D99G2B1R | GRANULE, FOR SUSPENSION / ORAL | 2.5 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET / ORAL | 25 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET / ORAL | 2240 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| caramel | CARAMEL | T9D99G2B1R | CAPSULE / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | CARBOXYMETHYLCELLULOSE CALCIUM | UTY7PDF93L | TABLET / ORAL | 967 mg | ||
| caramel | CARAMEL | T9D99G2B1R | LIQUID / ORAL | 5.3 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| caramel | CARAMEL | T9D99G2B1R | SOLUTION / ORAL | 11 mg | ||
| HYPROMELLOSE 2910 (15000 MPA.S) | HYPROMELLOSE 2910 (15000 MPA.S) | 288VBX44JC | TABLET / ORAL | 29 mg | ||
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET / ORAL | 2240 mg | ||
| caramel | CARAMEL | T9D99G2B1R | LIQUID / ORAL | 5.3 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sankaijo | DOCUSATE SODIUM, SENNOSIDES | Sato Pharmaceutical Co., Ltd. | 83c0d52b-f7e2-40b0-a01b-1ccee78f8f1b | 2023-11-29 | Warnings | 49873-404-01 49873-404 49873040401 0b54b2d1-83e7-3a18-e063-6394a90a5b58 83c0d52b-f7e2-40b0-a01b-1ccee78f8f1b |
Adverse event summaries are temporarily unavailable. Other product information remains available.